Fieldview Capital Management LLC Invests $1.36 Million in Doximity, Inc. $DOCS

Fieldview Capital Management LLC acquired a new position in Doximity, Inc. (NYSE:DOCS) in the 4th quarter, Holdings Channel.com reports. The firm acquired 30,729 shares of the company’s stock, valued at approximately $1,361,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of DOCS. Royal Bank of Canada increased its stake in shares of Doximity by 24.2% in the 1st quarter. Royal Bank of Canada now owns 106,845 shares of the company’s stock worth $6,200,000 after purchasing an additional 20,847 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Doximity by 0.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after purchasing an additional 210 shares in the last quarter. NewEdge Advisors LLC increased its stake in shares of Doximity by 613.7% in the 1st quarter. NewEdge Advisors LLC now owns 6,323 shares of the company’s stock worth $367,000 after purchasing an additional 5,437 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Doximity by 33.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 255,529 shares of the company’s stock worth $14,828,000 after purchasing an additional 63,873 shares in the last quarter. Finally, Focus Partners Wealth purchased a new stake in shares of Doximity in the 1st quarter worth $283,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Trading Down 0.1%

Shares of Doximity stock opened at $20.02 on Monday. The stock has a market capitalization of $3.66 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 3.41 and a beta of 1.30. The firm’s 50-day moving average price is $22.30. Doximity, Inc. has a twelve month low of $17.15 and a twelve month high of $76.51.

Insider Transactions at Doximity

In related news, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total value of $234,540.00. Following the completion of the transaction, the director owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. This trade represents a 31.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,444 shares of the stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the transaction, the insider directly owned 90,706 shares of the company’s stock, valued at approximately $1,851,309.46. The trade was a 2.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 16,180 shares of company stock valued at $395,110. Company insiders own 31.30% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCS has been the subject of a number of analyst reports. Jefferies Financial Group lowered Doximity from a “buy” rating to a “hold” rating and cut their price target for the stock from $51.00 to $19.00 in a research note on Thursday, May 14th. BTIG Research lowered Doximity from a “buy” rating to a “neutral” rating in a research note on Thursday, May 14th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $44.00 price target on shares of Doximity in a research note on Monday, March 9th. Canaccord Genuity Group cut their price target on Doximity from $34.00 to $30.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Finally, The Goldman Sachs Group cut their price target on Doximity from $28.00 to $24.00 and set a “neutral” rating for the company in a research note on Thursday, May 14th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $30.62.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.